Fractyl Health, Inc. (NASDAQ:GUTS)
| Market Cap | 20.56M-90.0% |
| Revenue (ttm) | 0-100.0% |
| Net Income | -105.65M-5.9% |
| EPS | -13.20+46.1% |
| Shares Out | 13.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 14,814,160 |
| Open | 2.12 |
| Previous Close | 4.16 |
| Day's Range | 1.54 - 2.30 |
| 52-Week Range | 1.53 - 29.34 |
| Beta | 2.42 |
| Analysts | Buy |
| Price Target | 5.00(+222.58%) |
| Earnings Date | Nov 11, 2026 |
Fractyl Health, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About GUTS
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$GUTS stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in GUTS holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by GUTS's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
GUTS Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New GUTS patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to GUTS from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in GUTS
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $2.52M |
| VXFVanguard Extended Market ETF | $1.08M |
Estimated from each fund’s disclosed top holdings × AUM
GUTS Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from GUTS’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score